Literature DB >> 10914723

Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay.

S Gelmini1, A Crisci, B Salvadori, M Pazzagli, C Selli, C Orlando.   

Abstract

Telomerase activity was measured with a quantitative assay, based on a modification of telomeric repeat amplification protocol method, in bladder cancers and apparently normal mucosa in 33 patients. In the same patients, the enzyme was also measured in exfoliated cells collected both with voided urine and bladder washings. Results obtained in urine were compared with those from 20 healthy subjects. Telomerase activity was present in 31 (94%) bladder cancer tissues and in 23 (72%) apparently normal mucosa samples. However, the levels of enzyme activity were significantly higher in cancer tissues in comparison with normal mucosa (mean +/- SD, 47.3 +/- 23.2 and 14.9 +/- 6.1 ng DNA/microg protein, respectively; P < 0.0001). Telomerase activity in bladder cancer tissues was not related to tumor stage and grade. Enzyme activity was present in 27 urine samples and in 27 (82%) bladder washings collected from cancer patients. We did not find correlation between the activity in urine and washings, and their mean levels were not different (22.2 +/- 10.1 and 20.7 +/- 8.0, respectively). Telomerase activity in bladder cancer tissues was correlated to its activity in urine (r = 0.650, P < 0.001) and in bladder washings (r = 0.410, P < 0.05). Only 2 of 20 urine samples from control subjects were found to express telomerase activity at a very low level. This was the first attempt to correlate telomerase activity in exfoliated cells from urine and bladder washings with the activity in corresponding bladder cancers. According to these results we postulate that telomerase activity in urine sediment reflects the activity in bladder cancers better than bladder washings and, for its easy collection, is to be preferred as diagnostic marker in this tumor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10914723

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  7 in total

1.  Telomerase activity detected by quantitative assay in bladder carcinoma and exfoliated cells in urine.

Authors:  R Fedriga; R Gunelli; O Nanni; F Bacci; D Amadori; D Calistri
Journal:  Neoplasia       Date:  2001 Sep-Oct       Impact factor: 5.715

2.  Bladder cancer 2000: molecular markers for the diagnosis of transitional cell carcinoma.

Authors:  D Chao; S J Freedland; A J Pantuck; A Zisman; A S Belldegrun
Journal:  Rev Urol       Date:  2001

3.  Telomerase Activity Analysis In Urine Sediment for Bladder Cancer.

Authors:  Valentina Casadio; Sara Bravaccini
Journal:  Methods Mol Biol       Date:  2021

4.  Urine telomerase: an important marker in the diagnosis of bladder cancer.

Authors:  Maria Aurora Sanchini; Sara Bravaccini; Laura Medri; Roberta Gunelli; Oriana Nanni; Franco Monti; Paolo Carlo Baccarani; Alberto Ravaioli; Eduard Bercovich; Dino Amadori; Daniele Calistri
Journal:  Neoplasia       Date:  2004 May-Jun       Impact factor: 5.715

5.  A system-level pathway-phenotype association analysis using synthetic feature random forest.

Authors:  Qinxin Pan; Ting Hu; James D Malley; Angeline S Andrew; Margaret R Karagas; Jason H Moore
Journal:  Genet Epidemiol       Date:  2014-02-17       Impact factor: 2.135

6.  Diagnostic Value of Telomerase Activity in Patients With Bladder Cancer: A Meta-Analysis of Diagnostic Test.

Authors:  Lei Peng; Jinze Li; Chunyang Meng; Jinming Li; Dandan Tang; Fangxue Guan; Peng Xu; Tangqiang Wei; Yunxiang Li
Journal:  Front Oncol       Date:  2020-12-03       Impact factor: 6.244

7.  The current role of telomerase in the diagnosis of bladder cancer.

Authors:  Sara Bravaccini; Valentina Casadio; Dino Amadori; Daniele Calistri; Rosella Silvestrini
Journal:  Indian J Urol       Date:  2009-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.